Prevention of colon cancer - Update 2008;Kolonkarzinom - Prävention 2008

Praxis

Volumn 97, Issue 20, 2008, Pages 1077-1083

  Vogt, Wolfgang ^a  

^a KLINIKUM ESSLINGEN   (Germany)

Author keywords

Adenoma; Colorectal cancer; Primary prevention; Secondary prevention

Indexed keywords

EID: 55349094339     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/1661-8157.97.20.1077     Document Type: Short Survey

References (17)

1. Schmiegel W., Pox C., Adler G. et al.: S3-Leitlinienkonferenz "Kolorektales Karzinom" 2004. Z Gastroenterol 2004; 42: 1129-1177
2. Renehan A.G.; Tyson M., Egger M. et al.: Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578 (Pubitemid 351232031)
3. Gatof D., Ahnen D.: Primary prevention of colorectal cancer: diet and drugs. Gastroenterol Clin N Am 2002; 31: 587-623. (Pubitemid 34761228)
4. Moskal A., Norat T., Ferrari P., Riboli E.: Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies. Int J Cancer 2007; 120: 664-671. (Pubitemid 44969039)
5. Cole B., Baron J.A., Sandler R.S. et al.: Folic acid for the prevention of colorectal adenomas. JAMA 2007; 297: 2351-2359.
6. Bjelakovic G., Nikolova D., Simonetti R.G., Gluud Ch.: Mortality in randomized trials of anti-oxidants supplements for primary and secondary prevention. JAMA 2007; 297: 842-857. (Pubitemid 46333949)
7. Flossmann E., Rothwell P.M.: Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007; 369: 1603-1613. (Pubitemid 46710123)
8. Chan A.T., Ogino S., Fuchs C. S.: Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 2007; 356: 2131-2142. (Pubitemid 47010839)
9. Arber N., Eagel C.J., Spicak J. et al.: Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006; 355: 885-895. (Pubitemid 44315981)
10. Baron J.A., Sandler R.S., Bresalier R.S. et al.: A randomized trial of Rofecoxib for the chemo-prevention of colorectal adenomas. Gastroenterology 2006; 131: 1674-1682. (Pubitemid 44958508)
11. Poynter J.N., Gruber S.B., Higgins P. et al.: Statins and the risk of colorectal cancer. N Engl J Med 2005; 352: 2184-2192. (Pubitemid 40727085)
12. Bonovas S., Filioussi K., Flordellis C.S., Sitaras N.M.: Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol 2007; 25: 3462-3468. (Pubitemid 47310884)
13. Winawer S.J., Zauber A.G., Ho M.N. et al.: Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329: 1977-1981. (Pubitemid 24015040)
14. levi Z., Rozen P., Hazazi R. et al.: A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007; 146: 244-255.
15. Guittet L., Bouvier V., Mariotte N. et al.: Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007; 56: 210-214.
16. Mulder S.A., van Leerdam M.E., van Vuuren A.J. et al.: Tumor pyruvat kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer. Eur J Gastroenterol Hepatol 2007; 19: 878-882. (Pubitemid 47415147)
17. Eisele R., Vogelsang E., Kraft K. et al.: Screening for colorectal lesions with high-resolution video colonoscopes in a German male average-risk population at 40 to 59 years of age. Z Gastroenterol 2007; 45: 952-957. (Pubitemid 47581174)